StockNews.com initiated coverage on shares of Organovo (NASDAQ:ONVO – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a sell rating on the medical research ...

Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Organovo Holdings Inc. (ONVO) on Friday reported a loss of $2.5 million in its fiscal second quarter. The San Diego-based company said it had a loss of 14 ...

SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel ...

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply ...

Find the latest Organovo Holdings, Inc. ONVO analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Short interest in Organovo Holdings Inc (NASDAQ:ONVO) increased during the last reporting period, rising from 32.50K to 39.07K. This put 0.26% of the company's publicly available shares short.

Organovo stock opened at $0.41 on Friday. Organovo has a 12-month low of $0.32 and a 12-month high of $1.74. The stock has a 50-day simple moving average of $0.43 and a 200 day simple moving ...

This page features the latest news about the Organovo Holdings stock. Organovo expands equity incentive plan following stockholder approval Organovo Holdings (NASDAQ:ONVO), Inc., a biotechnology ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...